Indoco Remedies Ltd (INDOCO) Stock Price & News

INDOCO:NSE

Indoco Remedies Ltd

₹210.00

+0.24%

(+0.50) 1D

Oct 30, 3:30:02 PM GMT+5:30 · INR

All symbols

	Symbol	Price	Change	% Change

Last report

Oct 27, 2026

Fiscal period

Q2 2027

- / -

Revenue / Est. (INR)

5.20B / 5.10B

Fiscal Q2 2027 earnings call

Waiting for the earnings call

At a glance

Insights from the latest news and reports

Previous reportsAll values in INR

Loading Previous Earnings...

All values in INR	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	4.45B	4.76B	4.68B	5.20B
Cost of goods sold	1.20B	2.11B	1.58B	1.80B
Cost of revenue	1.20B	2.11B	1.58B	1.80B
Research and development expenses	183.10M	177.59M	185.40M	209.80M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	1.06B	2.26B	1.01B	1.05B
Operating expense	3.25B	2.47B	3.03B	3.28B
Total operating expenses	4.46B	4.58B	4.61B	5.08B
Operating income	-5.00M	178.85M	64.90M	119.90M
Other non operating income	9.80M	-14.68M	21.80M	19.70M
EBT including unusual items	-313.10M	-250.05M	777.20M	241.90M
EBT excluding unusual items	-251.60M	-281.37M	-196.20M	-129.50M
Income tax expense	-18.60M	-13.22M	122.80M	47.20M
Effective tax rate	5.94%	5.28%	15.80%	19.51%
Other operating expenses	1.69B	-346.32M	1.48B	1.68B
Net income	-297.90M	-216.36M	649.90M	183.80M
Net profit margin	-6.69%	-4.55%	13.90%	3.53%
Earnings per share	-	-	-1.85	-
Interest and investment income	-	13.72M	-	-
Interest expense	-256.40M	-459.26M	-282.90M	-269.10M
Net interest expenses	-256.40M	-445.54M	-282.90M	-269.10M
Depreciation and amortization charges	320.10M	324.94M	345.30M	344.40M
EBITDA	242.70M	396.03M	381.02M	464.75M
Gain or loss from assets sale	-	-	-	-

Finance